機関投資家はヒューマナを 持株を削減したが 保険会社は 4Qの 予想を上回った Institutional investors cut holdings in Humana, but the health insurer beat Q4 earnings estimates.

複数の機関投資家が 医療保険会社のトップであるヒューマナ・インカーの 持分を大幅に削減した. Several institutional investors have reduced their holdings in Humana Inc., a leading health insurer, by significant percentages. それにもかかわらず,ヒューマナは第4四半期に1株当たり利益の予想をわずかに上回り,分析者のコンセンサスである2.26ドルと比較して2.16ドルを報告した. Despite this, Humana slightly beat earnings per share expectations in the fourth quarter, reporting ($2.16) compared to analysts' consensus of ($2.26). 株価は株当たり16.47ドルと予想されている. The company is projected to post earnings of 16.47 per share for the current fiscal year. ヒューマナの株は"Hold"の評価で 目標価格は280.17ドルで 最近は1株当たり0.885ドルの四半期配当を発表した Humana's stock has a "Hold" rating with a target price of $280.17, and it recently announced a quarterly dividend of $0.885 per share.